Open AccessManagement of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020
Author(s) -
В. Б. Гриневич,
И. В. Губонина,
V. L. Doshchitsin,
Yu. V. Kotovskaya,
Yu. A. Kravchuk,
В. И. Педь,
Е. И. Сас,
А. В. Сыров,
Artem V. Tarasov,
А. И. Тарзиманова,
О. Н. Ткачева,
Д. И. Трухан
Publication year - 2020
Publication title -
kardiovaskulârnaâ terapiâ i profilaktika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.158
H-Index - 16
eISSN - 2619-0125
pISSN - 1728-8800
DOI - 10.15829/1728-8800-2020-2630
Subject(s) - comorbidity , pandemic , medicine , context (archaeology) , covid-19 , intensive care medicine , disease management , coronavirus , disease , diabetes mellitus , medline , infectious disease (medical specialty) , paleontology , parkinson's disease , political science , law , biology , endocrinology
The pandemic of the novel coronavirus infection (COVID-19), caused by SARS‑CoV‑2, has become a challenge to healthcare systems in all countries of the world. Patients with comorbidity are the most vulnerable group with the high risk of adverse outcomes. The problem of managing these patients in context of a pandemic requires a comprehensive approach aimed both at the optimal management in self-isolated patients not visiting medical facilities, and management of comorbidities in patients with COVID-19. The presented consensus covers these two aspects of managing patients with cardiovascular disease, diabetes, chronic obstructive pulmonary disease, gastrointestinal disease, and also pay attention to the multiple organ complications of COVID-19.